Multiple Sclerosis Market To Reach USD 39.9 Billion By 2032, Report By DataHorizzon Research
April 25, 2024 08:50 ET
|
DataHorizzon Research
Fort Collins, Colorado, April 25, 2024 (GLOBE NEWSWIRE) -- Rise in cases of multiple sclerosis to trigger the need for vaccines and diagnosis. Multiple sclerosis (MS) is a condition characterized...
International Myeloma Foundation Holds 15th Annual Gala at the Edison Ballroom in New York City on April 18
April 25, 2024 08:45 ET
|
International Myeloma Foundation
On April 18, the International Myeloma Foundation held its 15th Annual Gala at the Edison Ballroom for the first time in New York, hosted by Ray Romano.
Acute Repetitive Seizures Market Predicted to Reach USD 7.94 Billion By 2032, With a Growth of 11.9% CAGR: Polaris Market Research
April 25, 2024 08:33 ET
|
Polaris Market Research & Consulting LLP
New York, NY, April 25, 2024 (GLOBE NEWSWIRE) -- According to Polaris Market Research, the global acute repetitive seizures market size and share was valued at USD 2.90 billion in 2023 and is...
Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024
April 25, 2024 07:00 ET
|
Morphic Therapeutic
MORF ends 1Q24 with $659 million, cash into 2H27; phase 2b study of MORF-057 in UC continues on target; anticipate GARNET phase 2 in Crohn's to begin 2Q
Regeneron and Mammoth Biosciences Collaborate to Pursue Next-Generation CRISPR-Based Gene Editing for Multiple Diseases
April 25, 2024 07:00 ET
|
Regeneron Pharmaceuticals, Inc.
Mammoth’s proprietary ultracompact CRISPR-based gene editing platform and Regeneron’s proprietary delivery technologies set to advance in vivo programs in multiple tissue and cell types Mammoth to...
Nucleome Therapeutics appoints Dr John Davis as Non-Executive Director of the Board and establishes Scientific Advisory Board of world-leading experts
April 25, 2024 07:00 ET
|
Nucleome Therapeutics
Nucleome Therapeutics appoints Dr John Davis as Non-Executive Director of the Board and establishes Scientific Advisory Board of world-leading experts John Davis brings direct clinical expertise as...
Biologic Therapeutics Drugs Market Size Projections Exhibit a CAGR of 12.2%%, Likely to Attain a Value of USD 1485.0 Billion by 2033
April 25, 2024 06:00 ET
|
The Brainy Insights
Newark, April 25, 2024 (GLOBE NEWSWIRE) -- The Brainy Insights estimates that the USD 469.7 billion biologic therapeutics drugs market will reach USD 1485.0 billion by 2033. Biologic therapeutics...
Life Sciences Market To Reach USD 9.6 Billion By 2032, Says DataHorizzon Research
April 25, 2024 02:40 ET
|
DataHorizzon Research
Fort Collins, Colorado, April 25, 2024 (GLOBE NEWSWIRE) -- Rapid technological advancements in the healthcare industry drive the industry growth. The life sciences industry is undergoing profound...
Communiqué de presse : Sanofi réitère ses objectifs financiers pour 2024, après une forte croissance de 7% portée par les lancements
April 25, 2024 01:30 ET
|
Sanofi - Aventis Groupe
Sanofi réitère...
Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance
April 25, 2024 01:30 ET
|
Sanofi - Aventis Groupe
Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance Paris, April 25, 2024 Sales growth of 6.7% at CER and business EPS(1) of €1.78 Dupixent sales up 24.9% to €2,835...